Company intelligence / Profile preview
Furen Pharmaceutical Group Co., Ltd.
Henan, Chinafuren.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Furen Pharmaceutical is a top 20 pharmaceutical group in China focused on R&D, manufacturing, and marketing of pharmaceuticals including traditional Chinese medicines and modern drugs. The company has multiple programs spanning from preclinical to commercial stages with approvals for certain products dating back to the late 1990s. Its pipeline includes small molecules, antibody fusion proteins, recombinant coagulation factors targeting indications such as hemophilia A, tinea pedis, asthma, cancer, and iron-deficiency anemia. It is also active in otitis media/sinusitis drug development.
- Therapeutic areas
- PulmonologyDermatologyOncologyHematology
- Modalities
- Small molecule drugsAntibody fusion proteinsRecombinant coagulation factors
- Industry
- Pharma
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Furen Pharmaceutical Group Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Furen Pharmaceutical Group Co., Ltd..